Literature DB >> 3126704

Radiometric method for pyrazinamide susceptibility testing of Mycobacterium tuberculosis in egg-yolk-enriched BACTEC 12A medium.

C L Woodley1, R W Smithwick.   

Abstract

A radiometric method for testing the susceptibility of Mycobacterium tuberculosis to pyrazinamide in egg-yolk-enriched 12A medium (pH 5.5) is described. We obtained 100% agreement between the 7H10 agar method with 25 microgram of pyrazinamide per ml and the modified radiometric method with a drug concentration of 50 microgram/ml in tests of 90 clinical isolates.

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3126704      PMCID： PMC172111          DOI： 10.1128/AAC.32.1.125

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  11 in total

1.  The use of egg-yolk dialysate for the growth of Mycobacterium tuberculosis.

Authors:  J O NORMAN; R P WILLIAMS
Journal:  Am Rev Respir Dis       Date:  1960-03

2.  Activation of pyrazinamide and nicotinamide in acidic environments in vitro.

Authors:  W McDERMOTT; R TOMPSETT
Journal:  Am Rev Tuberc       Date:  1954-10

3.  Growth of Mycobacterium tuberculosis in egg yolk mediums.

Authors:  A H EGGERTH
Journal:  Proc Soc Exp Biol Med       Date:  1950-04

4.  Evaluation of streptomycin and ethambutol concentrations for susceptibility testing of Mycobacterium tuberculosis by radiometric and conventional procedures.

Authors:  C L Woodley
Journal:  J Clin Microbiol       Date:  1986-02       Impact factor: 5.948

5.  Determination of drug susceptibility of mycobacteria to pyrazinamide in 7H10 agar.

Authors:  K D Stottmeier; R E Beam; G P Kubica
Journal:  Am Rev Respir Dis       Date:  1967-11

6.  Evaluation of a radiometric method for pyrazinamide susceptibility testing of Mycobacterium tuberculosis.

Authors:  J J Tarrand; A D Spicer; D H Gröschel
Journal:  Antimicrob Agents Chemother       Date:  1986-12       Impact factor: 5.191

7.  Radiometric method for testing susceptibility of mycobacteria to pyrazinamide in 7H12 broth.

Authors:  L B Heifets; M D Iseman
Journal:  J Clin Microbiol       Date:  1985-02       Impact factor: 5.948

8.  MYCOBACTERIA: LABORATORY METHODS FOR TESTING DRUG SENSITIVITY AND RESISTANCE.

Authors:  G CANETTI; S FROMAN; J GROSSET; P HAUDUROY; M LANGEROVA; H T MAHLER; G MEISSNER; D A MITCHISON; L SULA
Journal:  Bull World Health Organ       Date:  1963       Impact factor: 9.408

9.  Improved method for testing susceptibility of Mycobacterium tuberculosis to pyrazinamide.

Authors:  W R Butler; J O Kilburn
Journal:  J Clin Microbiol       Date:  1982-12       Impact factor: 5.948

10.  Evaluation of the BACTEC radiometric method for detection of 1% resistant populations of Mycobacterium tuberculosis.

Authors:  J J Tarrand; D H Gröschel
Journal:  J Clin Microbiol       Date:  1985-06       Impact factor: 5.948
View more
  7 in total

1.  Modified method for testing the quality of albumin-containing enrichments used in growth media for mycobacteria.

Authors:  W R Butler; N G Warren; G P Kubica; J O Kilburn
Journal:  J Clin Microbiol       Date:  1990-05       Impact factor: 5.948

2.  Effects of decontamination methods and culture conditions on viability of Mycobacterium ulcerans in the BACTEC system.

Authors:  J C Palomino; F Portaels
Journal:  J Clin Microbiol       Date:  1998-02       Impact factor: 5.948

3.  Effect of egg yolk on growth of Mycobacterium tuberculosis in 7H12 liquid medium.

Authors:  Y Kononov; K D Ta; L Heifets
Journal:  J Clin Microbiol       Date:  1988-07       Impact factor: 5.948

4.  Testing of susceptibility of Mycobacterium tuberculosis to pyrazinamide with the nonradiometric BACTEC MGIT 960 system.

Authors:  Gaby E Pfyffer; Frantiska Palicova; Sabine Rüsch-Gerdes
Journal:  J Clin Microbiol       Date:  2002-05       Impact factor: 5.948

5.  Multicenter evaluation of a nonweekend reading schedule for radiometric pyrazinamide susceptibility testing of Mycobacterium tuberculosis.

Authors:  B Madison; W Gross; I George; A Sloutsky; G Washabaugh; B Robinson-Dunn; H Lipman; B Metchock; G Mazurek; J Ridderhof
Journal:  J Clin Microbiol       Date:  2002-10       Impact factor: 5.948

6.  Processing respiratory specimens with C18-carboxypropylbetaine: development of a sediment resuspension buffer that contains lytic enzymes to reduce the contamination rate and lecithin to alleviate toxicity.

Authors:  C G Thornton; K M MacLellan; T L Brink; D M Wolfe; O J Llorin; S Passen
Journal:  J Clin Microbiol       Date:  1998-07       Impact factor: 5.948

7.  Drug susceptibility testing of Mycobacterium tuberculosis complex by use of a high-throughput, reproducible, absolute concentration method.

Authors:  Bert van Klingeren; Mirjam Dessens-Kroon; Tridia van der Laan; Kristin Kremer; Dick van Soolingen
Journal:  J Clin Microbiol       Date:  2007-05-30       Impact factor: 5.948
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.